Autosomal dominant polycystic kidney disease

被引:0
|
作者
Ferrer, Elisa [1 ]
Bozzo, Jordi [1 ]
机构
[1] Prous Sci, Barcelona 08080, Spain
关键词
D O I
10.1358/dof.2006.031.07.995040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of polycystic; kidney diseases, which are genetic disorders characterized by the abnormal growth of numerous cysts in the kidneys. ADPKD is one of the leading causes of endstage renal failure. It results from mutations in two genes, PKD1 and PKD2, with PKD1 mutations accounting for more than 80% of cases. Currently, there is no cure for ADPKD and traditional treatments have been supportive, aimed at ameliorating associated symptoms and complications. However, the advances in understanding the pathophysiology of this disease will lead to more targeted therapeutic strategies to prevent cyst formation.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 50 条
  • [31] Hypertension in Autosomal Dominant Polycystic Kidney Disease
    Chapman, Arlene B.
    Stepniakowski, Konrad
    Rahbari-Oskoui, Frederic
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 153 - 163
  • [32] Angiogenesis and autosomal dominant polycystic kidney disease
    Huang, Jennifer L.
    Woolf, Adrian S.
    Long, David A.
    PEDIATRIC NEPHROLOGY, 2013, 28 (09) : 1749 - 1755
  • [33] MRI in autosomal dominant polycystic kidney disease
    Zhang, Weiguo
    Blumenfeld, Jon D.
    Prince, Martin R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 50 (01) : 41 - 51
  • [34] Autosomal Dominant Polycystic Kidney Disease A Review
    Chebib, Fouad T.
    Hanna, Christian
    Harris, Peter C.
    Torres, Vicente E.
    Dahl, Neera K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [35] The Treatment of Autosomal Dominant Polycystic Kidney Disease
    Kuehn, E. Wolfgang
    Walz, Gerd
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (51-52): : 884 - 890
  • [36] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Jouret, Francois
    Krzesinski, Jean-Marie
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1258 - 1259
  • [37] Tolvaptan and Autosomal Dominant Polycystic Kidney Disease
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1988 - 1989
  • [38] Treatment of autosomal dominant polycystic kidney disease
    Torra, Roser
    MEDICINA CLINICA, 2014, 142 (02): : 73 - 79
  • [39] Autosomal dominant polycystic kidney disease in children
    Polubothu, Satyamaanasa
    Richardson, Amanda
    Kerecuk, Larissa
    Sinha, Manish D.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [40] Autosomal dominant polycystic kidney disease and transplantation
    Niemczyk, Mariusz
    Niemczyk, Stanislaw
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2009, 14 (04) : 86 - 90